EFFECTS OF ORAL MEMANTINE ON SYMPTOMS OF PARKINSONS-DISEASE - RESULTS OF A PLACEBO-CONTROLLED MULTICENTRIC STUDY

被引:91
作者
SCHNEIDER, E
FISCHER, PA
CLEMENS, R
BALZEREIT, F
FUNFGELD, EW
HAASE, HJ
机构
[1] UNIV ERLANGEN NURNBERG,NERVEN KLIN & POLIKLIN,D-8520 ERLANGEN,FED REP GER
[2] ALLGEMEINES KRANKENHAUS BARMBEK,NEUROL ABT,D-2000 HAMBURG 60,FED REP GER
[3] PSYCHIAT KRANKENHAUS,D-3550 MARBURG 1,FED REP GER
[4] PFALZKLIN LANDECK,D-6749 KLINGENMUNSTER,FED REP GER
关键词
D O I
10.1055/s-2008-1069311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:987 / 990
页数:4
相关论文
共 15 条
[1]   NEUROPHARMACOLOGICAL STUDIES ON D145 (1,3-DIMETHYL-5-AMINOADAMANTAN) [J].
COSTALL, B ;
NAYLOR, RJ .
PSYCHOPHARMACOLOGIA, 1975, 43 (01) :53-61
[2]  
FISCHER PA, 1977, ARZNEIMITTEL-FORSCH, V27, P1487
[3]  
GROSSMANN W, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1273
[4]  
GROSSMANN W, 1977, ARZNEIMITTEL-FORSCH, V27, P1483
[5]  
HORNYKIEWICZ O, 1982, 4 AD S
[6]  
MAJ J, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1256
[7]   PHARMACOLOGICAL EFFECTS OF 1,3-DIMETHYL-5-AMINOADAMANTANE, A NEW ADAMANTANE DERIVATIVE [J].
MAJ, J ;
SOWINSKA, H ;
BARAN, L ;
SARNEK, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 26 (01) :9-14
[8]   PHARMACOLOGICAL EVIDENCE FOR INVOLVEMENT OF GABA-ERGIC SYSTEM IN LOCOMOTOR STIMULATION PRODUCED IN MICE BY 1,3-DIMETHYL-5-AMINOADAMANTANE (D-145) [J].
MENON, MK ;
CLARK, WG .
NEUROPHARMACOLOGY, 1978, 17 (12) :1049-1052
[9]  
SACHS L, 1978, ANGEWANDTE STATISTIK
[10]  
SCHATTON W, 1981, MEMANTINE CHEM PHARM